Funding for this research was provided by:
INTERCOMPANY
Article History
Received: 24 July 2023
Accepted: 8 September 2023
First Online: 30 September 2023
Declarations
:
: Daniela Rau has received honoraria for speaking at scientific meetings, serving at scientific advisory boards and consulting activities from Bayer, Biogen, Celgene (BMS), Eli Lilly and Company, the healthcare business of Merck KGaA, Darmstadt, Germany, Novartis, Roche, Sanofi, and Teva. She has received research support from the healthcare business of Merck KGaA, Darmstadt, Germany. Beate Müller and Susanne Übler are employees of Merck Healthcare Germany GmbH, Weiterstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany.
: The study was performed in accordance with the 1964 Declaration of Helsinki, and its later amendments, and all applicable local rules and regulations. The CLAWIR study protocol and the informed consent form were approved by the local ethical review board (Landesärztekammer Baden-Württemberg, no. F-2020-147). All patients provided written informed consent to participate.